Cargando…
Recent advances in management of cerebrovascular diseases
A comprehensive approach to managing the vascular risk factors in both primary and secondary stroke prevention settings can lower the risk of first and recurrent stroke. Recent studies highlight the benefits of blood pressure treatment in the elderly, use of statins in healthy subjects with normal l...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924712/ https://www.ncbi.nlm.nih.gov/pubmed/20948732 http://dx.doi.org/10.3410/M1-49 |
_version_ | 1782185620981940224 |
---|---|
author | Khan, Khurshid Shuaib, Ashfaq |
author_facet | Khan, Khurshid Shuaib, Ashfaq |
author_sort | Khan, Khurshid |
collection | PubMed |
description | A comprehensive approach to managing the vascular risk factors in both primary and secondary stroke prevention settings can lower the risk of first and recurrent stroke. Recent studies highlight the benefits of blood pressure treatment in the elderly, use of statins in healthy subjects with normal low-density lipoprotein levels, and comparison of various anti-platelet agents. For acute stroke the efficacy of thrombolysis beyond 3 hours has recently been shown. |
format | Text |
id | pubmed-2924712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Medicine Reports Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-29247122010-10-14 Recent advances in management of cerebrovascular diseases Khan, Khurshid Shuaib, Ashfaq F1000 Med Rep Review Article A comprehensive approach to managing the vascular risk factors in both primary and secondary stroke prevention settings can lower the risk of first and recurrent stroke. Recent studies highlight the benefits of blood pressure treatment in the elderly, use of statins in healthy subjects with normal low-density lipoprotein levels, and comparison of various anti-platelet agents. For acute stroke the efficacy of thrombolysis beyond 3 hours has recently been shown. Medicine Reports Ltd 2009-06-29 /pmc/articles/PMC2924712/ /pubmed/20948732 http://dx.doi.org/10.3410/M1-49 Text en © 2009 Medicine Reports Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes |
spellingShingle | Review Article Khan, Khurshid Shuaib, Ashfaq Recent advances in management of cerebrovascular diseases |
title | Recent advances in management of cerebrovascular diseases |
title_full | Recent advances in management of cerebrovascular diseases |
title_fullStr | Recent advances in management of cerebrovascular diseases |
title_full_unstemmed | Recent advances in management of cerebrovascular diseases |
title_short | Recent advances in management of cerebrovascular diseases |
title_sort | recent advances in management of cerebrovascular diseases |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924712/ https://www.ncbi.nlm.nih.gov/pubmed/20948732 http://dx.doi.org/10.3410/M1-49 |
work_keys_str_mv | AT khankhurshid recentadvancesinmanagementofcerebrovasculardiseases AT shuaibashfaq recentadvancesinmanagementofcerebrovasculardiseases |